With AI-BIO
WHO WE ARE
History
-
2018
-
04
Establishment of Baobab Pharm Co., Ltd. at Yonsei University Seoul Korea
-
04
Inauguration of CEO Kyoung Tai No
-
07
Selected for a National grant of Bio-SPC for development of therapeutic agents by Ministry of Science & ICT
-
-
2019
-
04
Fund Raising 750M from Geno Focus
-
11
Inauguration of CEO In Sang Lee and CTO Kyoung Tai No(Each Representative)
-
-
2020
-
03
Selected for BIG3(Bio, Health) Project by Ministry of SMEe and Startups
-
04
Move to Yonsei University International Campus at Songdo Inchon
-
04
Company name changed to BaobabAiBio Co., Ltd.
-
04
Establishment of Company R&D Center
-
08
Certified as a Venture Business Company
-
10
Selected for a National grant of Drug development of colon cancer and rare diseases using artificial intelligence platforms by Ministry of SMEs and Start Ups
-
11
Selected for a National grant of Development of AI platform based first-in-class drug design to overcome drug-resistance of melanoma patients by Ministry of SMEs and Start Ups
-
12
Series A Fund Raising 4.5B
-
-
2021
-
02
Fund Raising
-
03
Series A Fund Raising 11.5B
-
05
Establishment of Gwang-Ju Branch
-
05
Research service contract with eFlask
-
06
Research service contract with MirimGene
-
09
Research service contract with Jeil Pharma
-
12
Set up Cryo-EM systems Aquilos2, Glacios(200K), Krios(300K)
-